Epigenetics in colorectal cancer

Current Opinion in Gastroenterology

Volumn 18, Issue 1, 2002, Pages 68-73

  Shen, Lanlan ^a   Issa, Jean Pierre J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DERIVATIVE; CYTOSINE PHOSPHOGUANOSINE; DNA; GROWTH FACTOR; UNCLASSIFIED DRUG;

ACETYLATION; AUTOCRINE EFFECT; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; CELL INVASION; CELL MOTILITY; COLORECTAL CARCINOMA; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HEREDITY; HUMAN; MICROSATELLITE INSTABILITY; PARACRINE SIGNALING; PHENOTYPE; PROMOTER REGION; REVIEW;

EID: 0036138384     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200201000-00012     Document Type: Review

References (71)

1. The hallmarks of cancer
2. Genetic instabilities in human cancers
3. Lessons form hereditary colorectal cancer
4. Methylation-induced repression-belts, braces, and chromatin
5. Alterations in DNA methylation - A fundamental aspect of neoplasia
6. Cancer epigenetics comes of age
7. The essentials of DNA methylation
8. Cytosine methylation and the ecology of intragenomic parasites
9. CpG islands and genes
10. Dynamics of DNA methylation during development
11. Histone methylation versus histone acetylation: New insights into epigenetic regulation
12. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia
13. The role of DNA methylation in cancer
14. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
15. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
16. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia
17. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair- defective human tumor cell lines
18. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
19. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns
20. The epigenetics of colorectal cancer
21. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
22. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)
23. 11q23 rearrangements in acute leukemia
24. Truncating mutations of hsnf5/ini1 in aggressive pediatric cancer
25. Relaxation of imprinted genes in human cancer
26. Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability
27. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer
28. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
29. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
30. Methylation of CpG loci in 5′-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines
31. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer
32. HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers
33. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells
34. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors
35. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene
36. Causes of microsatellite instability in colorectal tumors: Implications for hereditary non-polyposis colorectal cancer screening
37. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers
38. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
39. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers
40. CpG methylation is maintained in human cancer cells lacking DNMT1
41. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
42. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
43. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma
44. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma
45. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer
46. Hypermethylation et 9q32-33 tumor suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer
47. Aberrant promoter methylation of multiple genes in non-small cell lung cancers
48. Aging, DNA methylation, and cancer
49. Aging and DNA methylation in colorectal mucosa and cancer
50. CpG island methylator phenotypes in aging and cancer
51. Accelerated age-related CpG island methylation in ulcerative colitis
52. CpG island methylator phenotype in colorectal cancer
53. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
54. Late onset and high incidence of colon cancer of the mutator phenotype with hypermethylated hMLH1 gene in women
55. Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: Associations with clinicopathologic features
56. Methylation silencing and mutations of the p14ARF and p161NK4a genes in colon cancer
57. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability
58. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis
59. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis
60. Serrated route to colorectal cancer: Back street or super highway?
61. Folate and carcinogenesis: An integrated scheme
62. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer
63. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers
64. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer
65. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
66. Suppression of intestinal neoplasia by DNA hypomethylation
67. Dnmt1 N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+mice independently of p53 but demonstrates strong synergy with the modifier of Min 1 (AKR) resistance allele
68. Altering gene expression with 5-azecytidine
69. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
70. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
71. Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azecytidine-induced demethylation of the hMLH1 gene promoter